Answer
Oct 17, 2024 - 10:22 AM
The bioavailability of the medication is 13%. This means that 13% of the active ingredient reaches systemic circulation, which is typical for inhaled medications and ensures effective delivery to the lungs.
What is the bioavailability of the medication? Incruse Ellipta (Umeclidinium)
Status:
Open Oct 17, 2024 - 10:22 AM
Do you have the same question? Follow this Question
1answer
View More Product Details
Incruse Ellipta (Umeclidinium)
Incruse Ellipta Inhaler is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). Buy Incruse Ellipta Inhaler at Canada Pharmacy
View Details
